Enveric Biosciences, Inc. - 10-Q Filing

Enveric Biosciences reports Q3 2026 results with 4,475,884 shares of common stock outstanding as of November 11, 2026.

SEC EDGAR ·

Tickers: $ENVB

Read the full article at SEC EDGAR

More Regulatory news